Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-03-21

FDA Approved: DICLOFENAC SODIUM MISOPROSTOL — Supplemental Application (Nivagen Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Diclofenac Sodium with Misoprostol (Nivagen Pharmaceuticals, Inc.). The labeling supports use for relief of signs an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Diclofenac Sodium with Misoprostol (diclofenac sodium and misoprostol)

Snippet

SUPPL AP for DICLOFENAC SODIUM MISOPROSTOL (DICLOFENAC SODIUM AND MISOPROSTOL)